TRV0109101, a G Protein-Biased Agonist of the µ-Opioid Receptor, Does Not Promote Opioid-Induced Mechanical Allodynia following Chronic Administration-Reference-Cited by-同舟云学术

TRV0109101, a G Protein-Biased Agonist of the µ-Opioid Receptor, Does Not Promote Opioid-Induced Mechanical Allodynia following Chronic Administration

Published:2017-05-22 Issue:2 Volume:362 Page:254-262
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Koblish Michael,Carr Richard,Siuda Edward R.,Rominger David H.,Gowen-MacDonald William,Cowan Conrad L.,Crombie Aimee L.,Violin Jonathan D.,Lark Michael W.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference46 articles.

1. Opioid-induced Hyperalgesia

2. SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

3. μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence

4. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice;Bohn;J Neurosci,2002

5. Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical tools for the opioids;Molecular and Cellular Neuroscience;2023-06

2. Biased Signaling through G Protein-coupled Receptors;YAKUGAKU ZASSHI;2022-10-01

3. The Evolution of Our Understanding of “ GPCRs ”;GPCRs as Therapeutic Targets;2022-09-16

4. Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology;Pharmacology & Therapeutics;2022-02

5. Preclinical discovery and development of oliceridine (Olinvyk®) for the treatment of post-operative pain;Expert Opinion on Drug Discovery;2022-01-06